Abstract | BACKGROUND: OBJECTIVE: We evaluate the molecular mechanisms of imiquimod-induced apoptosis and autophagy in skin cancer cell lines. METHODS: The Mcl-1, Bcl-2 and Bcl-xL proteins were determined by immunoblotting. The Mcl-1 mRNA level was examined by RT-PCR and real-time PCR. The mechanisms of imiquimod-induced decrease in Mcl-1 protein were evaluated by addition of cycloheximide, MG132 proteasome inhibitor or pan- caspase inhibitor. The phosphorylation of eIF4E, 4E-BP1 and eEF2 in imiquimod treated cells were examined by immunoblotting. The imiquimod-induced apoptosis and autophagy were evaluated in Mcl-1-overexpressing cells by XTT test, mitochondrial membrane potential measurement, DNA content assay, LC3 immunoblotting, EGFP-LC3 puncta formation and quantification of acidic vesicular organelle with acridine orange staining. RESULTS: The decrease in the Mcl-1 protein level was faster and stronger than the decrease in Bcl-2 and Bcl-xL in imiquimod-treated skin cancer cells. The imiquimod-induced decrease in Mcl-1 protein was not caused by blocked transcription or the promotion of degradation but was associated with inactivation of translation factors in BCC cells. The Mcl-1-overexpressing BCC cells were more resistant to intrinsic cellular apoptosis than control BCC cells during imiquimod treatment. Mcl-1 overexpression in BCC cells resulted in the basal activation of autophagy but did not modulate imiquimod-induced autophagy or rescue imiquimod-induced autophagic cell death in BCC cells. CONCLUSIONS:
Imiquimod may rapidly downregulate Mcl-1 protein levels by inhibiting translation in skin cancer cells. Mcl-1 may act to protect against apoptosis but not autophagy and autophagic cell death during imiquimod treatment in skin cancer cells.
|
Authors | Shi-Wei Huang, Chia-Che Chang, Chi-Chen Lin, Jaw-Ji Tsai, Yi-Ju Chen, Chun-Ying Wu, Kuang-Ting Liu, Jeng-Jer Shieh |
Journal | Journal of dermatological science
(J Dermatol Sci)
Vol. 65
Issue 3
Pg. 170-8
(Mar 2012)
ISSN: 1873-569X [Electronic] Netherlands |
PMID | 22305615
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Aminoquinolines
- Biomarkers, Tumor
- Myeloid Cell Leukemia Sequence 1 Protein
- Proto-Oncogene Proteins c-bcl-2
- RNA, Messenger
- bcl-X Protein
- Imiquimod
|
Topics |
- Aminoquinolines
(pharmacology)
- Apoptosis
(drug effects)
- Autophagy
(drug effects)
- Biomarkers, Tumor
(metabolism)
- Carcinoma, Basal Cell
(metabolism, pathology)
- Cell Line, Tumor
- Down-Regulation
(drug effects)
- Humans
- Imiquimod
- Myeloid Cell Leukemia Sequence 1 Protein
- Proto-Oncogene Proteins c-bcl-2
(metabolism)
- RNA, Messenger
(metabolism)
- Skin Neoplasms
(metabolism, pathology)
- Up-Regulation
(drug effects)
- bcl-X Protein
(metabolism)
|